Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes

Introduction: Diabetic nephropathy (DN) is a microvascular complication of diabetes. DN is clinically manifested as an increase in urine albumin excretion. Total white blood cell count is a crude but sensitive indicator of inflammation and studied in many cardiac and noncardiac diseases as an inflam...

Full description

Bibliographic Details
Main Authors: Sagar Ashokrao Khandare, Sachin Chittawar, Nitin Nahar, T N Dubey, Zahraan Qureshi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=387;epage=392;aulast=Khandare
_version_ 1831723665528455168
author Sagar Ashokrao Khandare
Sachin Chittawar
Nitin Nahar
T N Dubey
Zahraan Qureshi
author_facet Sagar Ashokrao Khandare
Sachin Chittawar
Nitin Nahar
T N Dubey
Zahraan Qureshi
author_sort Sagar Ashokrao Khandare
collection DOAJ
description Introduction: Diabetic nephropathy (DN) is a microvascular complication of diabetes. DN is clinically manifested as an increase in urine albumin excretion. Total white blood cell count is a crude but sensitive indicator of inflammation and studied in many cardiac and noncardiac diseases as an inflammatory marker such as acute myocardial infarction, stroke, and heart failure. In this study, the association of neutrophil-lymphocyte ratio (NLR) with DN is studied. Patients and Methods: It is an observational cross-sectional study. Totally 115 diagnosed type 2 diabetes mellitus patients were registered in this study. NLR was calculated by analyzing differential leukocyte count in complete blood picture. Albuminuria was tested by MICRAL-II TEST strips by dipstick method. Results: Totally 115 diabetic patients were registered. About 56 patients had DN and 59 had normal urine albumin. Mean NLR for a normal group is 1.94 ± 0.65 and in DN group is 2.83 ± 0.85 which was highly significant (P < 0.001). Estimated glomerular filtration rate (P = 0.047) and serum glutamate pyruvate transaminase (P < 0.001) were also significant. Conclusion: The results of our study show that there was a significant relation between NLR and DN. Therefore, NLR may be considered as a novel surrogate marker of DN in early stages.
first_indexed 2024-12-21T04:06:22Z
format Article
id doaj.art-2600754421834ec2ab7f785ada04c4c0
institution Directory Open Access Journal
issn 2230-8210
language English
last_indexed 2024-12-21T04:06:22Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Endocrinology and Metabolism
spelling doaj.art-2600754421834ec2ab7f785ada04c4c02022-12-21T19:16:34ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102017-01-0121338739210.4103/ijem.IJEM_476_16Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetesSagar Ashokrao KhandareSachin ChittawarNitin NaharT N DubeyZahraan QureshiIntroduction: Diabetic nephropathy (DN) is a microvascular complication of diabetes. DN is clinically manifested as an increase in urine albumin excretion. Total white blood cell count is a crude but sensitive indicator of inflammation and studied in many cardiac and noncardiac diseases as an inflammatory marker such as acute myocardial infarction, stroke, and heart failure. In this study, the association of neutrophil-lymphocyte ratio (NLR) with DN is studied. Patients and Methods: It is an observational cross-sectional study. Totally 115 diagnosed type 2 diabetes mellitus patients were registered in this study. NLR was calculated by analyzing differential leukocyte count in complete blood picture. Albuminuria was tested by MICRAL-II TEST strips by dipstick method. Results: Totally 115 diabetic patients were registered. About 56 patients had DN and 59 had normal urine albumin. Mean NLR for a normal group is 1.94 ± 0.65 and in DN group is 2.83 ± 0.85 which was highly significant (P < 0.001). Estimated glomerular filtration rate (P = 0.047) and serum glutamate pyruvate transaminase (P < 0.001) were also significant. Conclusion: The results of our study show that there was a significant relation between NLR and DN. Therefore, NLR may be considered as a novel surrogate marker of DN in early stages.http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=387;epage=392;aulast=KhandareDiabetic nephropathyinflammationmicrovascularneutrophil-lymphocyte ratiourine albumin
spellingShingle Sagar Ashokrao Khandare
Sachin Chittawar
Nitin Nahar
T N Dubey
Zahraan Qureshi
Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes
Indian Journal of Endocrinology and Metabolism
Diabetic nephropathy
inflammation
microvascular
neutrophil-lymphocyte ratio
urine albumin
title Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes
title_full Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes
title_fullStr Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes
title_full_unstemmed Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes
title_short Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes
title_sort study of neutrophil lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes
topic Diabetic nephropathy
inflammation
microvascular
neutrophil-lymphocyte ratio
urine albumin
url http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=3;spage=387;epage=392;aulast=Khandare
work_keys_str_mv AT sagarashokraokhandare studyofneutrophillymphocyteratioasnovelmarkerfordiabeticnephropathyintype2diabetes
AT sachinchittawar studyofneutrophillymphocyteratioasnovelmarkerfordiabeticnephropathyintype2diabetes
AT nitinnahar studyofneutrophillymphocyteratioasnovelmarkerfordiabeticnephropathyintype2diabetes
AT tndubey studyofneutrophillymphocyteratioasnovelmarkerfordiabeticnephropathyintype2diabetes
AT zahraanqureshi studyofneutrophillymphocyteratioasnovelmarkerfordiabeticnephropathyintype2diabetes